It is a hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. Our qualitative approach regarding the domain enabled us to merge as a trusted organization engaged in offering Atovaquone. This drug is used to prevent or treat a serious lung infection called Pneumocystis pneumonia. This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath. Atovaquone is a highly lipophilic drug that closely resembles the structure ubiquinone. This drug can act by selectively affecting mitochondrial electron transport and parallel processes such as ATP and pyrimidine biosynthesis.
Product Name : Atovaquone
Chemical Names : Mepron; Wellvone; Acuvel; Malarone Pediatric; Atovaquone & Interleukin 12
Molecular Formula : C22H19ClO3
Molecular Weight : 366.841 g/mol
IUPAC Name : 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
CAS Number : 94015-53-9
Color : Crystals from acetonitrile
Melting Point : 216-219 Â°C
Solubility : Practically insoluble in water
Drug Indication: For the treatment or prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX).